Patents by Inventor Jagdeep Singh Walia

Jagdeep Singh Walia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and gene therapy constructs for treating GM2 gangliosidoses
    Patent number: 11628226
    Abstract: Disclosed are novel gene therapy constructs containing both HEXA and HEXB genes to treat GM2 gangliosidoses, including Sandhoff disease and Tay-Sach's disease. Also described are co-treatments using chaperone and anti-inflammatory agents to enhance the effects of gene therapy.
    Type: Grant
    Filed: May 20, 2021
    Date of Patent: April 18, 2023
    Assignees: Queen's University at Kingston, Kingston Health Sciences Centre
    Inventor: Jagdeep Singh Walia
  • Methods and Gene Therapy Constructs for Treating GM2 Gangliosidoses
    Publication number: 20220072151
    Abstract: Disclosed are novel gene therapy constructs containing both HEXA and HEXB genes to treat GM2 gangliosidoses, including Sandhoff disease and Tay-Sach's disease. Also described are co-treatments using chaperone and anti-inflammatory agents to enhance the effects of gene therapy.
    Type: Application
    Filed: May 20, 2021
    Publication date: March 10, 2022
    Inventor: Jagdeep Singh Walia
  • Methods and gene therapy constructs for treating GM2 gangliosidoses
    Patent number: 11045557
    Abstract: Disclosed are novel gene therapy constructs containing both HEXA and HEXB genes to treat GM2 gangliosidoses, including Sandhoff disease and Tay-Sach's disease. Also described are co-treatments using chaperone and anti-inflammatory agents to enhance the effects of gene therapy.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: June 29, 2021
    Assignees: Queen's University at Kingston, Kingston Health Sciences Centre
    Inventor: Jagdeep Singh Walia
  • Methods and Gene Therapy Constructs for Treating GM2 Gangliosidoses
    Publication number: 20180028685
    Abstract: Disclosed are novel gene therapy constructs containing both HEXA and HEXB genes to treat GM2 gangliosidoses, including Sandhoff disease and Tay-Sach's disease. Also described are co-treatments using chaperone and anti-inflammatory agents to enhance the effects of gene therapy.
    Type: Application
    Filed: June 8, 2017
    Publication date: February 1, 2018
    Inventor: Jagdeep Singh Walia